Abstract: Disclosed are an organic semiconductor compound that exhibits chemical resistance and etch resistance while maintaining electrical characteristics and thus is applicable to an existing photolithography process, thereby increasing process efficiency, and an organic semiconductor device using the same.
Type:
Application
Filed:
November 15, 2018
Publication date:
May 23, 2019
Applicants:
FOUNDATION OF SOONGSIL UNIVERSITY-INDUSTRY COOPERA TION, Industry-University Cooperation Foundation Hanyang University
Inventors:
Do Hwan KIM, Hojin LEE, Han Wool PARK, Keun-Yeong CHOI, Moon Sung KANG, Haejung HWANG, Ji Hye SHIN
Abstract: Disclosed is a liquid hydrogen storage material, and more particularly, a hydrogen storage material which contains m-phenyltoluene (m=2, 3) and undergoes reversible dehydrogenation/hydrogenation reactions or contains a binary eutectic mixture or a ternary eutectic mixture of m-phenyltoluene (m=2, 3, 4).
Type:
Application
Filed:
November 16, 2018
Publication date:
May 23, 2019
Applicant:
Korea University Research and Business Foundation
Abstract: Multiscale brain electrodes can be used for spatiotemporal mapping, probing, and therapeutic modulation of the human brain. The applications for such functional mapping and electrical stimulation modulation span, for example, neurological and psychiatric diseases, and brain rehabilitation.
Type:
Application
Filed:
May 10, 2017
Publication date:
May 23, 2019
Applicant:
Mayo Foundation for Medical Education and Research
Inventors:
Benjamin H. Brinkmann, Squire M. Stead, Gregory A. Worrell
Abstract: An apparatus for trapping and sensing nanoparticles using plasmonic nanopores, comprising a conductive transparent layer, a conductive film layer mounted to a substrate, the film layer comprising a plurality of nanopores for trapping nanoparticles contained in a fluid situated between the conductive transparent layer and the conductive film layer, and an electric field source connected between the transparent layer and the film layer.
Type:
Application
Filed:
January 15, 2019
Publication date:
May 23, 2019
Applicant:
Purdue Research Foundation
Inventors:
Justus C. Ndukaife, Alexandra Boltasseva, Agbai Nnanna
Abstract: An introduction arrangement for a fenestrated or branched stent graft intended for deployment into the lumen of a vessel having a blind vessel extending from it. The introducer has a distal end intended to remain outside a patient in use and a proximal end with a nose cone dilator and an arrangement to retain the branched stent graft distally of the nose cone dilator. A sheath on the introducer extends over the branched stent graft to the nose cone dilator. An indwelling catheter extends from the distal end of the introducer and enters the fenestration or side arm and through to the nose cone dilator, the indwelling catheter has a guide wire extending through it. The guide wire can be extended beyond the nose cone dilator in use before the sheath is withdrawn from the branched stent graft so that it can be snared from the contra-lateral artery.
Type:
Application
Filed:
January 24, 2019
Publication date:
May 23, 2019
Applicants:
Cook Medical Technologies LLC, The Cleveland Clinic Foundation
Inventors:
David Ernest Hartley, John Lennon Anderson, Roy K. Greenberg, Wolf Stelter
Abstract: The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery systems and tissues or organ which are targeted as sites for delivery. Also provided are vectors and vector systems some of which encode one or more components of a SIN CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing SIN CRISPR complex formation in eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity and to edit or modify a target site in a genomic locus of interest to alter or improve the status of a disease or a condition.
Type:
Application
Filed:
January 30, 2019
Publication date:
May 23, 2019
Applicants:
The Broad Institute, Inc., Massachusetts Institute of Technology, University of Iowa Research Foundation
Abstract: Materials and methods are provided herein for determining if a subject has, or is at risk of developing, a clinical condition (e.g., cervical cancer). For example, this document provides a cost-effective self-test for determining whether a biological fluid from a subject contains a high-risk HPV strain, and a method for use of the self-test.
Type:
Application
Filed:
May 10, 2017
Publication date:
May 23, 2019
Applicant:
Mayo Foundation for Medical Education and Research
Abstract: A method for user-based application grouping in a table-top multi-user environment where a plurality of users execute applications individually comprises collecting geometric information of each window of a plurality of applications displayed on a table-top display—each window of the plurality of applications has different geometric information according to the position at which each user uses the table-top display; and processing geometric information of each window of the plurality of applications through a clustering algorithm processing unit by using the collected geometric information as a criterion for classifying the plurality of applications and grouping the processed geometric information for each user. Through grouping of applications currently executed in a table-top environment for each user, a user-specific special function such as a user-specific application history may be provided.
Type:
Application
Filed:
November 13, 2018
Publication date:
May 23, 2019
Applicant:
Research & Business Foundation Sungkyunkwan University
Inventors:
Young Ik EOM, Jong Gyu PARK, IN Hyeok KIM
Abstract: The present invention relates to a composition including nonanal or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating hair loss or promoting hair development, and more particularly, to a pharmaceutical composition, a quasi-drug composition, a cosmetic composition and a health functional food composition, which include nonanal or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating hair loss or promoting hair development or growth. The composition of the present invention may include a natural compound as an active ingredient, have no side effects during long-term administration for treating hair loss, which is a chronic disease, and exhibit excellent and stable efficacy in hair development and hair growth, and therefore it can be effectively used as compositions for an agent for preventing or treating hair loss, and a drug a quasi-drug, a cosmetic, or health functional food for promoting hair development or growth.
Type:
Application
Filed:
October 25, 2018
Publication date:
May 23, 2019
Applicant:
Industry-Academic Cooperation Foundation, Yonsei University
Abstract: A reactor configuration is proposed for selectively converting gaseous, liquid or solid fuels to a syngas specification which is flexible in terms of H2/CO ratio. This reactor and system configuration can be used with a specific oxygen carrier to hydro-carbon fuel molar ratio, a specific range of operating temperatures and pressures, and a co-current downward moving bed system. The concept of a CO2 stream injected in-conjunction with the specified operating parameters for a moving bed reducer is claimed, wherein the injection location in the reactor system is flexible for both steam and CO2 such that, carbon efficiency of the system is maximized.
Type:
Application
Filed:
April 12, 2017
Publication date:
May 23, 2019
Applicant:
Ohio State Innovation Foundation
Inventors:
Liang-shih FAN, Abbey EMPFIELD, Mandar KATHE, Charles FRYER, Elena BLAIR
Abstract: A method for producing hydrocarbons from glycerol. The method includes packing a catalyst comprising a noble metal and a support material into a reactor, introducing a reactant mixture containing glycerol into the reactor such that the reactant mixture containing methane is in close contact with the reactant mixture, and heating the reactant mixture containing glycerol to a temperature for a contact time.
Abstract: A process disclosed herein is related to the isolation and purification of substantially pure chemicals, including silica gel, sodium silicate, aluminum silicate, iron oxide, and rare earth elements (or rare earth metals, REEs), from massive industrial waste coal ash. In one embodiment, the process includes a plurality of caustic extractions of coal ash at an elevated temperature, followed by an acidic treatment to dissolve aluminum silicate and REEs. The dissolved aluminum silicate is precipitated out by pH adjustment as a solid product while REEs remain in the solution. REEs are captured and enriched using an ion exchange column. Alternatively, the solution containing aluminum silicate and REEs is heated to produce silica gel, which is easily separated from the enriched REEs solution. REEs are then isolated and purified from the enriched solution to afford substantially pure individual REE by a ligand-assisted chromatography.
Type:
Application
Filed:
November 16, 2018
Publication date:
May 23, 2019
Applicant:
Purdue Research Foundation
Inventors:
Nien-Hwa Linda Wang, Hoon Choi, David Harvey
Abstract: This document provides materials and methods for treating a damaged optic nerve in a mammal to restore visual function comprising administering a population of induced pluripotent stem cell-derived oligodendrocyte precursor cells. This document also provides materials and methods for determining a remyelination potential quotient of a population of induced pluripotent stem cell-derived oligodendrocyte precursor cells. This document also provides materials and methods for screening factors that enhance maturation or myelination efficiency of an induced pluripotent stem cell-derived oligodendrocyte precursor cell or cells.
Type:
Application
Filed:
April 3, 2017
Publication date:
May 23, 2019
Applicant:
Mayo Foundation for Medical Education and Research
Inventors:
Charles L. Howe, Miranda M. Standiford, Kanish Mirchia
Abstract: A photonic structure can include in one aspect one or more waveguides formed by patterning of waveguiding material adapted to propagate light energy. Such waveguiding material may include one or more of silicon (single-, poly-, or non-crystalline) and silicon nitride.
Type:
Grant
Filed:
January 8, 2018
Date of Patent:
May 21, 2019
Assignee:
The Research Foundation for The State University of New York
Inventors:
Douglas Coolbaugh, Thomas Adam, Gerald L. Leake
Abstract: An operating configuration for a power system during a particular time period may be derived from a net load forecast for the power system during the particular time period. The operating configuration may be based on characteristics of power generation units (PGUs) available within the power system (e.g., power generators). The characteristics of a PGU may include a generation trajectory for the PGU that defines, inter alia, power generated by the PGU as the PGU ramps up power production within the power system. The generation trajectory of PGUs may be evaluated in view of the net load forecast to ensure that adequate power resources are available within the power system and avoid ramping scarcity conditions.
Type:
Grant
Filed:
October 7, 2016
Date of Patent:
May 21, 2019
Assignees:
University of Utah Research Foundation, Arizona Board of Regents for and on behalf of Arizona State University
Abstract: Systems and methods that establish a pressure differential across a tissue wall to encourage complete decellularization of the wall are described. The methods can be utilized for decellularization of blood vessel tissue including heart valves and surrounding tissues. The methods and systems can essentially completely decellularize the treated tissue segments. Systems can be utilized to decellularize one or multiple tissue segments at a single time.
Type:
Grant
Filed:
July 23, 2015
Date of Patent:
May 21, 2019
Assignee:
Clemson University Research Foundation
Inventors:
Leslie Sierad, Eliza Laine Shaw, George Fercana, Dan Simionescu
Abstract: A system of selecting a keyframe for iterative closest point (ICP) includes a reference frame selector that generates a reference frame according to a current frame and a current keyframe; an ICP loop unit that performs ICP on the reference frame and the current frame, thereby generating a pose of the current frame; and a keyframe update unit that generates a new keyframe according to an offset condition between the pose of the current frame and a pose of the reference frame.
Type:
Grant
Filed:
September 14, 2017
Date of Patent:
May 21, 2019
Assignees:
NCKU Research and Development Foundation, Himax Technologies Limited
Inventors:
Ming-Der Shieh, Chun-Wei Chen, Ting-Yu Lin, Der-Wei Yang
Abstract: The presently disclosed and/or claimed inventive concept(s) relates generally to oxidative oxidized reaction products made from the mechanocatalytic oxidative depolymerization of lignin. More particularly, but without limitation, the mechanocatalytic oxidative depolymerization of lignin is performed in a non-aqueous/non-solvent based and solvent-free process, i.e., via a solid-solid mechanocatalytic oxidative reaction methodology. In one particular embodiment, the process of making such oxidative oxidized reaction products includes, without limitation, the step of mechanocatalytically reacting an oxidation catalyst with lignin or a lignin-containing material. The oxidative reaction products obtained from the process include, for example, at least one of vanillin, and syringealdehyde, vanillic acid, and syringic acid.
Type:
Grant
Filed:
March 7, 2014
Date of Patent:
May 21, 2019
Assignee:
University of Central Florida Research Foundation Inc
Abstract: The present application discloses the unexpected result that a neuroactive steroid such as B260 can act as a general anesthetic and that it has no neurotoxic side effects such as impairing brain development.
Type:
Grant
Filed:
March 30, 2015
Date of Patent:
May 21, 2019
Assignee:
University of Virginia Patent Foundation
Abstract: The present invention relates to a composition for prevention or treatment of bronchial asthma comprising a PKR inhibitor as an active ingredient. The PKR inhibitor and derivatives thereof according to the present invention can be used as a pharmaceutical for prevention, amelioration or treatment of bronchial asthma and as a supplementary health food because the PKR inhibitor and derivatives thereof reduce the total counts of inflammatory cells, eosinophils, neutrophils and lymphocytes in bronchoalveolar lavage fluid of neutrophilic severe asthma-induced mice, reduce airway inflammation and airway hyper-responsiveness, and reduce inflammatory mediators.
Type:
Grant
Filed:
December 16, 2015
Date of Patent:
May 21, 2019
Assignee:
Undustrial Cooperation Foundation Chonbuk National University